Unified Compliance Platform Implementation Case Study

This case study details how LENZ Therapeutics, a U.S.-based late-stage biotech company, consolidated its Quality, Regulatory, and Trial Master File (TMF) archive management to eliminate recurring costs associated with Contract Research Organizations (CROs) and enhance operational efficiency in preparation for commercialization. As LENZ advanced from Phase III clinical trials, it faced challenges due to fragmented systems and reliance on CROs, which hindered real-time visibility and increased operational drag. By implementing Ennov's unified platform, LENZ achieved a streamlined data model that reduced costs and cognitive load, enabling continuous inspection readiness without additional staffing. The case study outlines the strategic consolidation process, emphasizing the importance of internal data ownership and cross-domain visibility. It also highlights the economic impact of eliminating CRO fees and avoiding the need for additional administrative hires, allowing the team to focus on strategic growth. The results demonstrate how a unified compliance platform can transform operational velocity and mitigate risks associated with system fragmentation.